Brooklyn FI LLC Invests $1.39 Million in UnitedHealth Group Incorporated (NYSE:UNH)

Brooklyn FI LLC acquired a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) in the fourth quarter, HoldingsChannel.com reports. The firm acquired 2,752 shares of the healthcare conglomerate’s stock, valued at approximately $1,392,000.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the company. Wallace Capital Management Inc. increased its holdings in shares of UnitedHealth Group by 0.9% in the 3rd quarter. Wallace Capital Management Inc. now owns 2,119 shares of the healthcare conglomerate’s stock worth $1,239,000 after purchasing an additional 19 shares in the last quarter. Western Pacific Wealth Management LP boosted its holdings in shares of UnitedHealth Group by 2.2% during the 4th quarter. Western Pacific Wealth Management LP now owns 902 shares of the healthcare conglomerate’s stock valued at $456,000 after acquiring an additional 19 shares during the last quarter. MCF Advisors LLC raised its holdings in shares of UnitedHealth Group by 0.8% during the fourth quarter. MCF Advisors LLC now owns 2,578 shares of the healthcare conglomerate’s stock valued at $1,304,000 after purchasing an additional 20 shares during the last quarter. Axiom Financial Strategies LLC boosted its holdings in UnitedHealth Group by 3.6% in the fourth quarter. Axiom Financial Strategies LLC now owns 575 shares of the healthcare conglomerate’s stock worth $291,000 after purchasing an additional 20 shares during the last quarter. Finally, 44 Wealth Management LLC lifted its holdings in shares of UnitedHealth Group by 1.6% during the 4th quarter. 44 Wealth Management LLC now owns 1,309 shares of the healthcare conglomerate’s stock valued at $662,000 after buying an additional 21 shares during the period. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

UnitedHealth Group stock opened at $503.05 on Thursday. The company has a market cap of $460.14 billion, a PE ratio of 32.45, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The company’s 50-day moving average price is $510.48 and its 200-day moving average price is $548.22.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same period in the prior year, the firm posted $5.83 EPS. The firm’s revenue was up 6.8% compared to the same quarter last year. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were paid a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.67%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s dividend payout ratio is currently 54.19%.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on UNH shares. Stephens upped their price objective on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research report on Thursday, December 5th. Wells Fargo & Company dropped their price objective on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a report on Tuesday, January 28th. Piper Sandler decreased their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research report on Thursday, January 2nd. Oppenheimer raised their target price on UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. Finally, Cantor Fitzgerald reissued an “overweight” rating and set a $700.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. Twenty investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, UnitedHealth Group presently has a consensus rating of “Buy” and a consensus price target of $629.32.

Insider Buying and Selling

In related news, Director Timothy Patrick Flynn bought 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the transaction, the director now owns 4,500 shares in the company, valued at $2,302,065. The trade was a 28.57 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.33% of the stock is currently owned by insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.